Assessment of Biochemical Profiles in Premenopausal and Postmenopausal Women with Breast Cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3385-3388

  Yadav, Naval Kishor ^a,b   Poudel, Bibek ^a,b   Thanpari, C ^a,c   Koner, Bidhan Chandra ^a,d  

^a Department of Biochemistry ^*  (Nepal)

^b MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

^c Nepalgunj Medical College   (Nepal)

^d MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Breast cancer; Nepal; Postmenopausal; Premenopausal

Indexed keywords

EID: 84873588206     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3385     Document Type: Article

References (36)

1. Abu-Bedair FA, El-Gamal BA, Ibrahim NA, et al (2003). Serum lipids and tissue DNA content in Egyptian female breast cancer patients. Jpn J Clin Oncol, 33, 278-82
2. Banu S, Adem V, Sakine C, et al (2003). Association between oxidative stress and selenium levels in patients with breast cancer at different clinical stages. J Trace Elements in Experimental Medicine, 16, 87-94.
3. Benson JR, Jatoi I, Keisch M, et al (2009). Early breast cancer. Lancet, 373, 1463-79.
4. Brandt A, Bermejo JL, Sundquist J, et al (2010). Age of onset in familial breast cancer as background data for medical surveillance. Br J Cancer, 102, 42-7.
5. Charalabopoulos K, Kotsalos A, Batistatou A, et al (2006). Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. Br J Can, 95, 674-6.
6. Chow LW, Cheng CW, Wong JL, et al (2005). Serum lipid profiles in patients receiving endocrine treatment for breast cancer--the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial. Biomed Pharmacother, 59, 302-5.
7. Conlon MS, Johnson KC, Bewick MA, et al (2010). Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer. Cancer Epidemiol, 34, 142-9.
8. Cuzick J (2010). Breast cancer prevention in the developing World. Breast Cancer Res, 12, 9.
9. Datta K, Choudhuri M, Guha S, et al (2012). Breast Cancer Scenario in a Regional Cancer Centre in Eastern India over Eight Years - Still a Major Public Health Problem. Asian Pac J Cancer Prev, 13, 809-13.
10. Frier BM, Ashby JP, Nairn IM, et al (1981). Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide. Diab Metab, 7, 45-9.
11. Furberg AS, Veierod MB, Wilsgaard T, et al (2004). Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst, 96, 1152-60.
12. Garland M, Morris JS, Stampfer MJ, et al (1995). Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst, 87, 497-505.
13. Gooden PJ, Boyd NF, Hanna W, et al (1997). Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer, 27, 284-92.
14. Hadjisawas A, Loizidou MA, Middleton N, et al (2010). An investigation of breast cancer risk factors in Cyprus: a case control study. BMC Cancer, 10, 447.
15. Hortobagyi GN, De La Garza Salazar J, Pritchard K, et al (2005). The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer, 6, 391-401.
16. Horwitz DL, Kuzuya L, Rubenstein AR (1976). Circulating serum C- peptide: A brief review of diagnostic implications. N Eng J Med, 295, 207-18.
17. Hoyer AP, Engholm G (1992). Serum lipids and breast cancer risk: a cohort study of 5, 207 Danish women. Cancer Causes Control, 3, 403-8.
18. Irwin ML, Duggan C, Wang CY, et al (2011). Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol, 29, 47-53.
19. Jasim BT (2011). Determination the Erythrocyte glutathione peroxidase activity and Serum selenium level in patients with breast cancer. Tikrit J Pure Sci, 16, 4-8.
20. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
21. Kokoglu E, Karaarslan I, Karaarslan HM, et al (1994). Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett, 82, 175-8.
22. Kuru B, Özaslan C, Özdemir P, et al (2002). Risk factors for breast cancer in Turkish women with early pregnancies and long-lasting lactation. Acta Oncol, 6, 556-61.
23. Liao S, Li J, Wang L, et al (2010). Type 2 Diabetes Mellitus and Characteristics of Breast Cancer in China. Asian Pac J Cancer Prev, 11, 933-7.
24. Lopez-Saez JB, Martinez-Rubio JA, Alvarez MM, et al (2008). Metabolic profile of breast cancer in a population of women in southern Spain. Open Clin Cancer J, 18, 1-6.
25. Mahabir S, Baer DJ, Johnson LL, et al (2006). Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 15, 2502-7.
26. Mannisto S, Alfathan G, Virtanen M, et al (2000). Toenail selenium and breast cancer a case-control study in Finland. Eur J Clin Nutr, 54, 98-103.
27. McPherson K, Steel CM, Dixon JM (2000). Breast cancer-epidemiology, risk factors, and genetics. BMJ, 321, 624-8.
28. Owiredu WK, Donkor S, Addai BM, et al (2009). Serum lipid profile of breast cancer patients. Pak J Biol Sci, 12, 332-8.
29. Qi XY, Zhang AY, Wu GL, et al (1994). The association between breast cancer and diet and other factors. Asia Pac J Public Health, 7, 98-104.
30. Ray G, Husain SA (2001). Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem, 34, 71-6.
31. Schootman M, Jeffe D, Lian M, et al (2009). The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis. Am J Epidemiol, 169, 554-61.
32. Sezer H, Yilmaz M, Gurler H, et al (2011). Breast cancer risk factors in Turkey: a hospital-based case-control study. Asian Pac J Cancer Prev, 12, 2317-22.
33. Singh YP, Sayami P (2009). Management of breast cancer in Nepal. J Nepal Med Association, 48, 252-7.
34. Takatani O, Okumoto T, Kosano H (1991). Genesis of breast cancer in Japanese: a possible relationship between sex hormone-binding globulin (SHBG) and serum lipid components. Breast Cancer Res Treat, 18, 527-9.
35. Vona-Davis L, Rose DP (2009). The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health, 18, 883-93.
36. Zielinski CC, Stuller I, Rausch P, et al (1988). Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer. J Can Res Clin Oncol, 114, 514-8.